Vaccination Uptake (VAX) in PD

NACompletedINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

April 12, 2018

Study Completion Date

April 12, 2018

Conditions
Parkinson's Disease
Interventions
BEHAVIORAL

Standard of Care

BEHAVIORAL

Home Visit Program (HVP)

The study team will also contact the subject by phone within one week of each vaccination visit to assess for any adverse effects related to vaccination, included but not limited to: injection site pain, tenderness, swelling, pruritus, induration, or erythema; systemic symptoms such as fatigue, chills, headache, anorexia, malaise, myalgias, or anaphylaxis. Subjects will be contacted 90 days (+ 14 days) following Visit 3 to inquire about any additional symptoms and healthcare utilization.

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02874274 - Vaccination Uptake (VAX) in PD | Biotech Hunter | Biotech Hunter